Introduction: Although combined therapy with peritoneal dialysis (PD) and hemodialysis (HD) is widespread in Japan, its clinical utility has been reported only in retrospective or before-and-after test lacking a control group.
Methods: We conducted a prospective, multicenter, observational cohort study of 176 incident PD patients and compared patient survival and changes in clinical parameters between patients on different dialysis modalities.
Results: During a median follow-up of 41 months, 47 patients transferred to combined therapy and 35 patients transferred directly to HD. Patients transferred to combined therapy had a significantly better survival than those transferred directly to HD. However, we could not establish this difference in a multivariate analysis because only six patients died among these groups. The decreases in urea nitrogen and serum creatinine were more prominent among patients directly transferred to HD.
Conclusion: This is the first report revealing clinical feasibility of transfer to combined therapy for PD patients.
Keywords: dialysate-to-plasma ratio of creatinine (D/P Cr); fluid overload; inadequate dialysis; residual renal function (RRF); β2 microglobulin.
© 2022 International Society for Apheresis and Japanese Society for Apheresis.